Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$100.78 - $112.29 $24,187 - $26,949
-240 Reduced 9.56%
2,271 $247,000
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $155,072 - $182,530
-1,601 Reduced 38.93%
2,511 $254,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $120,345 - $141,184
-1,266 Reduced 23.54%
4,112 $451,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $520,375 - $602,497
5,378 New
5,378 $520,000
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $193,834 - $236,368
-1,700 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $198,322 - $219,402
1,700 New
1,700 $201,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tempus Wealth Planning, LLC Portfolio

Follow Tempus Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tempus Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tempus Wealth Planning, LLC with notifications on news.